BOB体育

Skip to main content
(352) 733-0111

Modernizing Instructions to Improve Treatment Participation During First Radiotherapy

  • Status
    Accepting Candidates
  • Age
    18 Years - 99 Years
  • Sexes
    All
  • Healthy Volunteers
    No
I'm interested
Share this study

Objective

Daily patient participation is critical to the successful, life-saving delivery of radiotherapy. There is very little in the literature describing the best way to prepare patients to give optimal participation. This study aims to look at an already-prepared conversion of patient instruction materials and measure whether the improvement in clarity and specificity produces the desired changes in patient decision-making and emotional comfort.

Details

Full study title Modernizing Instructions to Improve Treatment Participation of Subjects During Their First Radiotherapy
Protocol number OCR43106
ClinicalTrials.gov ID NCT06246409
Phase N/A

Eligibility

Inclusion Criteria:

  • Patients 鈮� 18 years old planning their first external beam radiotherapy

  • Written informed consent obtained from the subject and the subject agrees to comply with all the study-related procedures.

Exclusion Criteria:

  • Have received external beam radiotherapy in the past

  • External beam radiotherapy is initiated as inpatient.

  • External beam radiotherapy consists of less than 3 fractions.

  • Planned radiotherapy that does not employ an external beam

  • Planned participation in a clinical study that prohibits participation in a second, concurrent treatment trial

  • Prisoners or subjects who are involuntarily incarcerated, or subjects who are compulsorily detained for treatment of either a psychiatric or physical illness.

Lead researcher

  • Kathryn E Hitchcock, MD, PhD
    Cancer Specialist (Oncologist), Radiation Oncologist
    Languages: Spanish
    Kathryn E Hitchcock

Participate in a study

Here are some general steps to consider when participating in a research study:

  1. Step
    1

    Contact the research team

    Call or email the research team listed within the specific clinical trial or study to let them know that you're interested. A member of the research team, such as the researcher or study coordinator, will be available to tell you more about the study and to answer any questions or concerns you may have.

    Primary contact

  2. Step
    2

    Get screened to confirm eligibility

    You may be asked to take part in prescreening to make sure you are eligible for a study. The prescreening process ensures it is safe for you to participate. During the prescreening process, you will be asked some questions and you may also be asked to schedule tests or procedures to confirm your eligibility.

  3. Step
    3

    Provide your consent to participate

    If you are eligible and want to join the clinical trial or study, a member of the research team will ask for your consent to participate. To give consent, you will be asked to read and sign a consent form for the study. This consent form explains the study's purpose, procedures, risks, benefits and provides other important information, such as the study team's contact information.

  4. Step
    4

    Participate

    If you decide to participate in a clinical trial or study, the research team will keep you informed of the study requirements and what you will need to do to throughout the study. For some trials or studies, your health care provider may work with the research team to ensure there are no conflicts with other medications or treatments.